Infective Endocarditis Associated with Implantable Cardiac Device by Metallo-β-Lactamase-Producing Pseudomonas aeruginosa, Successfully Treated with Source Control and Cefiderocol Plus Imipenem

Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0131322. doi: 10.1128/aac.01313-22. Epub 2023 Feb 23.
No abstract available

Keywords: Pseudomonas aeruginosa; biofilm; cefiderocol; endocarditis; metallo-β-lactamase.

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefiderocol
  • Defibrillators, Implantable*
  • Endocarditis*
  • Humans
  • Imipenem / therapeutic use
  • Microbial Sensitivity Tests
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa
  • beta-Lactamases / genetics

Substances

  • Imipenem
  • Anti-Bacterial Agents
  • beta-Lactamases